Skip to main content
Erschienen in: European Radiology 9/2013

01.09.2013 | Hepatobiliary-Pancreas

Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI

verfasst von: Dominik Geisel, Lutz Lüdemann, Thomas Keuchel, Maciej Malinowski, Daniel Seehofer, Martin Stockmann, Bernd Hamm, Bernhard Gebauer, Timm Denecke

Erschienen in: European Radiology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To prospectively evaluate the early development of regional liver function after right portal vein embolisation (PVE) with Gd-EOB-DTPA-enhanced MRI in patients scheduled for extended right hemihepatectomy.

Methods

Ten patients who received a PVE before an extended hemihepatectomy were examined before and 14 days after PVE using Gd-EOB-DTPA-enhanced MRI of the liver. In these sequences representative region of interest measurements were performed in the embolised right (RLL) and the non-embolised left liver lobe (LLL). The volume as well as hepatic uptake index (HUI) was calculated independently for each lobe.

Results

Relative enhancement 14 days after PVE decreased in the RLL and increased significantly in the LLL (P < 0.05). Average hepatic uptake index (HUI) for RLL was significantly lower 14 days after PVE than before PVE (P < 0.05) and significantly higher for LLL (P < 0.05).

Conclusions

A significant shift of contrast uptake from the right to the left liver lobe can be depicted as early as 14 days after right PVE by using Gd-EOB-DTPA-enhanced MRI, which could reflect the redirected portal venous blood flow and the rapid utilisation of a hepatic functional reserve.

Key Points

• Preoperative portal vein embolisation (PVE) is widely performed before right-sided hepatic resection.
• PVE increases intravenous contrast medium uptake in the left lobe of liver.
• The hepatic uptake index for the left liver lobe increases rapidly after PVE.
• Left liver lobe function increase may be visualised by Gd-EOB-DTPA-enhanced MRI.
Literatur
1.
Zurück zum Zitat Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features. Am J Med 2:241–256CrossRef Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis: an unusual tumor with distinctive clinical and pathological features. Am J Med 2:241–256CrossRef
2.
Zurück zum Zitat Neuhaus P, Jonas S, Bechstein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 6:808–818CrossRef Neuhaus P, Jonas S, Bechstein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 6:808–818CrossRef
3.
Zurück zum Zitat Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 6:872–880CrossRef Dinant S, Gerhards MF, Rauws EAJ, Busch ORC, Gouma DJ, van Gulik TM (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 6:872–880CrossRef
4.
Zurück zum Zitat Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 4:656CrossRef Agrawal S, Belghiti J (2011) Oncologic resection for malignant tumors of the liver. Ann Surg 4:656CrossRef
5.
Zurück zum Zitat Jonas S, Benckert C, Thelen A, Lopez-Hänninen E, Rösch T, Neuhaus P (2008) Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 3:263CrossRef Jonas S, Benckert C, Thelen A, Lopez-Hänninen E, Rösch T, Neuhaus P (2008) Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 3:263CrossRef
6.
Zurück zum Zitat Neuhaus P, Thelen A, Jonas S et al (2012) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 5:1602–1608CrossRef Neuhaus P, Thelen A, Jonas S et al (2012) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 5:1602–1608CrossRef
7.
Zurück zum Zitat Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM (2004) Protection of the liver during hepatic surgery. Surg Gastrointest Surg 3:313–327CrossRef Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM (2004) Protection of the liver during hepatic surgery. Surg Gastrointest Surg 3:313–327CrossRef
8.
Zurück zum Zitat Breitenstein S, Apestegui C, Petrowsky H, Clavien PA (2009) “State of the art” in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg 4:797–803CrossRef Breitenstein S, Apestegui C, Petrowsky H, Clavien PA (2009) “State of the art” in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg 4:797–803CrossRef
9.
Zurück zum Zitat Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 1:49–57CrossRef Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 1:49–57CrossRef
10.
Zurück zum Zitat Madoff DC, Abdalla EK, Vauthey JN (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 6:779–790CrossRef Madoff DC, Abdalla EK, Vauthey JN (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 6:779–790CrossRef
11.
Zurück zum Zitat Denecke T, Seehofer D, Steffen IG et al (2011) Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 9:1254–1262CrossRef Denecke T, Seehofer D, Steffen IG et al (2011) Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 9:1254–1262CrossRef
12.
Zurück zum Zitat van Lienden KP, van den Esschert JW, de Graaf W et al (2012) Portal vein embolization before liver resection: a systematic review. Cardiovasc Interv Radiol 1:25–34 van Lienden KP, van den Esschert JW, de Graaf W et al (2012) Portal vein embolization before liver resection: a systematic review. Cardiovasc Interv Radiol 1:25–34
13.
Zurück zum Zitat Abdalla EK, Hicks ME, Vauthey JN (2002) Portal vein embolization: rationale, technique and future prospects. Br J Surg 2:165–175 Abdalla EK, Hicks ME, Vauthey JN (2002) Portal vein embolization: rationale, technique and future prospects. Br J Surg 2:165–175
14.
Zurück zum Zitat Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2:208 Farges O, Belghiti J, Kianmanesh R et al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2:208
15.
Zurück zum Zitat Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 5:686 Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 5:686
16.
Zurück zum Zitat Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 9:1255–1259CrossRef Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 9:1255–1259CrossRef
17.
Zurück zum Zitat Redaelli CA, Dufour JF, Wagner M et al (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 1:77CrossRef Redaelli CA, Dufour JF, Wagner M et al (2002) Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 1:77CrossRef
18.
Zurück zum Zitat Stockmann M, Lock JF, Riecke B et al (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 1:119–125CrossRef Stockmann M, Lock JF, Riecke B et al (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 1:119–125CrossRef
19.
Zurück zum Zitat de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 6:825–834CrossRef de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 6:825–834CrossRef
20.
Zurück zum Zitat Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 6:1323–1331CrossRef Nilsson H, Nordell A, Vargas R, Douglas L, Jonas E, Blomqvist L (2009) Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI. J Magn Reson Imaging 6:1323–1331CrossRef
21.
Zurück zum Zitat Seyama Y, Kokudo N (2009) Assessment of liver function for safe hepatic resection. Hepatol Res 2:107–116CrossRef Seyama Y, Kokudo N (2009) Assessment of liver function for safe hepatic resection. Hepatol Res 2:107–116CrossRef
22.
Zurück zum Zitat Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 8:567–576CrossRef Nilsson H, Blomqvist L, Douglas L, Nordell A, Jonas E (2010) Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB (Oxford) 8:567–576CrossRef
23.
Zurück zum Zitat Lee NK, Kim S, Lee JW et al (2009) Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 6:1707–1724CrossRef Lee NK, Kim S, Lee JW et al (2009) Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 6:1707–1724CrossRef
24.
Zurück zum Zitat Shimizu J, Dono K, Gotoh M et al (1999) Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 7:1330–1337CrossRef Shimizu J, Dono K, Gotoh M et al (1999) Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging. Dig Dis Sci 7:1330–1337CrossRef
25.
Zurück zum Zitat Kim T, Murakami T, Hasuike Y et al (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 4:683–688CrossRef Kim T, Murakami T, Hasuike Y et al (1997) Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA. J Magn Reson Imaging 4:683–688CrossRef
26.
Zurück zum Zitat Motosugi U, Ichikawa T, Sou H et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 5:1042–1046CrossRef Motosugi U, Ichikawa T, Sou H et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 5:1042–1046CrossRef
27.
Zurück zum Zitat Nishie A, Asayama Y, Ishigami K et al (2012) MR prediction of liver fibrosis using a liver-specific contrast agent: superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging 3:664–671CrossRef Nishie A, Asayama Y, Ishigami K et al (2012) MR prediction of liver fibrosis using a liver-specific contrast agent: superparamagnetic iron oxide versus Gd-EOB-DTPA. J Magn Reson Imaging 3:664–671CrossRef
28.
Zurück zum Zitat Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology 3:727–733CrossRef Yamada A, Hara T, Li F et al (2011) Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology 3:727–733CrossRef
29.
Zurück zum Zitat Norén B, Forsgren MF, Dahlqvist Leinhard O et al (2012) Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol 23:174–181PubMedCrossRef Norén B, Forsgren MF, Dahlqvist Leinhard O et al (2012) Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Eur Radiol 23:174–181PubMedCrossRef
30.
Zurück zum Zitat Saito K, Ledsam J, Sourbron S et al (2012) Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging. doi:10.1002/jmri.23907 Saito K, Ledsam J, Sourbron S et al (2012) Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. J Magn Reson Imaging. doi:10.​1002/​jmri.​23907
31.
Zurück zum Zitat Kim HJ, Kim BS, Kim MJ et al (2012) Enhancement of the liver and pancreas in the hepatic arterial dominant phase: Comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 tesla MRI in the same patient. J Magn Reson Imaging. doi:10.1002/jmri.23874 Kim HJ, Kim BS, Kim MJ et al (2012) Enhancement of the liver and pancreas in the hepatic arterial dominant phase: Comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 tesla MRI in the same patient. J Magn Reson Imaging. doi:10.​1002/​jmri.​23874
32.
Zurück zum Zitat Wakabayashi H, Ishimura K, Okano K et al (2002) Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 1:26CrossRef Wakabayashi H, Ishimura K, Okano K et al (2002) Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 1:26CrossRef
33.
Zurück zum Zitat de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM (2011) Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2:294–302CrossRef de Graaf W, Bennink RJ, Heger M, Maas A, de Bruin K, van Gulik TM (2011) Quantitative assessment of hepatic function during liver regeneration in a standardized rat model. J Nucl Med 2:294–302CrossRef
34.
Zurück zum Zitat Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1:77CrossRef Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1:77CrossRef
35.
Zurück zum Zitat Wang H, Cao Y (2012) Correction of arterial input function in dynamic contrast-enhanced MRI of the liver. J Magn Reson Imaging 2:411–421CrossRef Wang H, Cao Y (2012) Correction of arterial input function in dynamic contrast-enhanced MRI of the liver. J Magn Reson Imaging 2:411–421CrossRef
36.
Zurück zum Zitat Morris-Stiff G, Gomez D, Prasad R (2009) Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg 2:374–385CrossRef Morris-Stiff G, Gomez D, Prasad R (2009) Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg 2:374–385CrossRef
37.
Zurück zum Zitat Tajima T, Takao H, Akai H et al (2010) Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 3:362–366CrossRef Tajima T, Takao H, Akai H et al (2010) Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 3:362–366CrossRef
38.
Zurück zum Zitat Dahlqvist Leinhard O, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 3:642–653CrossRef Dahlqvist Leinhard O, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 3:642–653CrossRef
39.
Zurück zum Zitat de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM (2009) Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 2:423–430CrossRef de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM (2009) Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 2:423–430CrossRef
Metadaten
Titel
Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI
verfasst von
Dominik Geisel
Lutz Lüdemann
Thomas Keuchel
Maciej Malinowski
Daniel Seehofer
Martin Stockmann
Bernd Hamm
Bernhard Gebauer
Timm Denecke
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 9/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2859-1

Weitere Artikel der Ausgabe 9/2013

European Radiology 9/2013 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.